Catapres-TTS: a two year posttrial followup.
Kellaway
G S
GS
Lubbe
W F
WF
D000279:Administration, Cutaneous; D003000:Clonidine / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D011358:Product Surveillance, Postmarketing
D003000:Clonidine